News

Under provisions in its Constitution and Procedure, the Prescription Medicines Code of Practice Authority (PMCPA) advertises brief details of all cases where companies are ruled in breach of

The delta analyzer facilitates surgeons by providing key information in just 5-10 minutes which enables surgical team to decide whether platelets, plasma, red blood cells or other blood

The funding was supported under the Small Business Innovation Research (SBIR) program to provide on-going support for Kineta’s work on a new class of antiviral drugs. The antiviral

The trial expects to evaluate women with a prior history of recurrent BV, and the product will be used every second day. The company will recruit around 200

The collaboration allows to bring MJFF’s Parkinson’s Progression Markers Initiative (PPMI) clinical study to Australia. The Shake It Up Foundation will raise funds for PPMI and other Parkinson’s

Sinovac’s net income was $1.88m, compared to $1.56m for the same period in the prior year. The company’s operating income was $3.13m for the second quarter ended 30

Following the signing of the expended deal, SOBI has placed an additional order for vials of Ruconest from Pharming. The shipment forms part of SOBI’s preparation for the

The licensing deal allows Roche to get milestone payments from Chugai Pharma. Chugai Pharma intends to begin a Phase I clinical trial for BRAF mutation-positive metastatic melanoma in

Prior to Addex, Chowrira worked as the senior vice president & chief operating officer of Nektar Therapeutics till January 2011. Before Nektar, Chowrira worked as the executive director